The effect of COVID-19 on Multiple Sclerosis relapse: A systematic review and meta-analysis
Description
BACKGROUND: Multiple Sclerosis (MS) is a chronic autoimmune disease, affecting over 2.5 million people worldwide. There has been growing concern about the impact of COVID-19 on the clinical course of MS. However, these findings remain controversial
